Table 1.
By subject (N=37) | |
Age (years) | 66.0±11.9 |
Sex (F/M), no | 27/10 |
Race (white/black/asian), no. | 25/6/6 |
By eye (N=40) | |
Diagnosis (glaucoma/glaucoma suspect), no | 23/17 |
IOP during OCT follow-up (mmHg) | 14.5±3.1 |
IOP at the beginning of OCT follow-up (mmHg) | 15.0±4.2 |
Axial length (mm) | 24.24±1.16 |
CCT (μm) | 546.1±44.0 |
SAP MD at DH (dB) | −3.75±5.12 |
SAP PSD at DH (dB) | 4.38±3.39 |
Baseline RNFL thickness (μm) | |
Global | 80.63±14.69 |
Inferior | 89.64±23.86 |
Superior | 98.80±20.60 |
Temporal | 70.43±15.65 |
Nasal | 63.43±16.69 |
Location of DH | |
Inferior | 22 (55%) |
Superior | 14 (35%) |
Temporal | 3 (8%) |
Nasal | 1 (3%) |
Detected number of DH (multiple/single) | 9/31 |
Number of glaucoma medications at the beginning of OCT follow-up | 1.9±1.1 |
CCT = central corneal thickness; DH = disc hemorrhage; MD = mean deviation; PSD = pattern standard deviation; RNFL = retinal nerve fiber layer.
Values are shown as mean ± standard deviation.